Overview
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide and melanocortin receptor agonist derived from Melanotan II. This peptide has been investigated in scientific literature for its interactions with melanocortin receptor subtypes (MC1R-MC5R) and its biochemical properties in neuroendocrine signaling models. PT-141 serves as a valuable research tool for studying melanocortin receptor pharmacology, neuropeptide signaling cascades, and related biological pathways in controlled laboratory settings.
Specifications
- Form: Lyophilized powder
- Peptide Structure: Cyclic heptapeptide, melanocortin receptor agonist
- Purity: ≥98% by HPLC
- Molecular Weight: ~1,025 Da
- Appearance: White to off-white lyophilized powder
- Solubility: Soluble in sterile 0.9% saline
Storage
- Store at 2-8°C in original sealed packaging
- Protect from light and moisture
- Reconstituted solutions stable for 24 hours at 2-8°C
RESEARCH USE ONLY. Not for human consumption, injection, or medical treatment. Not approved by the FDA for research purposes.
